Chad Stoner

2-Substituted Aminopyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones. Structure−Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer Activity

S. KLUTCHKO, James M. Hamby, Diane H. Boschelli et al. · Journal of Medicinal Chemistry · 1998 · 130 citations · Full text

Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery

Chad Stoner, Adriaan Cleton, Kjell Johnson et al. · International Journal of Pharmaceutics · 2003 · 61 citations

Pharmaceutical Research, Preclinical Drug Evaluation, Oral Bioavailability Projection +10

Discovery of a Series of Imidazo[4,5-<i>b</i>]pyridines with Dual Activity at Angiotensin II Type 1 Receptor and Peroxisome Proliferator-Activated Receptor-γ

Agustin Casimiro‐Garcia, Gary F. Filzen, Declan Flynn et al. · Journal of Medicinal Chemistry · 2011 · 52 citations · Full text

Implementation of an ADME enabling selection and visualization tool for drug discovery

Chad Stoner, Eric Gifford, Charles J. Stankovic et al. · Journal of Pharmaceutical Sciences · 2004 · 50 citations

Drug Target, Engineering, Hit Identification +12

Integrated in Silico−in Vitro Strategy for Addressing Cytochrome P450 3A4 Time-Dependent Inhibition

Michael Zientek, Chad Stoner, Robyn R. Ayscue et al. · Chemical Research in Toxicology · 2010 · 50 citations

Automated Assay, Drug Target, Time-dependent Inhibition +18